Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CODX NASDAQ:HSCS NASDAQ:QNRX NASDAQ:TNON On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCODXCo-Diagnostics$2.21-3.1%$3.86$1.26▼$46.50$8.16M2.843.13 million shs121,895 shsHSCSHeartSciences$2.44-2.4%$2.25$1.63▼$4.30$7.76M1.781.04 million shs36,193 shsQNRXQuoin Pharmaceuticals$4.37-0.2%$4.63$3.25▼$41.80$8.78M1.52156,312 shs9,675 shsTNONTenon Medical$0.20+0.1%$0.48$0.18▼$2.48$2.34M1.363.65 million shs252,164 shs The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCODXCo-Diagnostics-3.39%-8.43%-26.92%+33.33%-74.18%HSCSHeartSciences+1.63%-2.34%+41.24%+22.55%-35.57%QNRXQuoin Pharmaceuticals+2.82%+4.04%-0.68%-23.56%-47.54%TNONTenon Medical-2.77%-2.43%-68.32%-75.85%-82.26%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCODXCo-Diagnostics$2.21-3.1%$3.86$1.26▼$46.50$8.16M2.843.13 million shs121,895 shsHSCSHeartSciences$2.44-2.4%$2.25$1.63▼$4.30$7.76M1.781.04 million shs36,193 shsQNRXQuoin Pharmaceuticals$4.37-0.2%$4.63$3.25▼$41.80$8.78M1.52156,312 shs9,675 shsTNONTenon Medical$0.20+0.1%$0.48$0.18▼$2.48$2.34M1.363.65 million shs252,164 shs The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCODXCo-Diagnostics-3.39%-8.43%-26.92%+33.33%-74.18%HSCSHeartSciences+1.63%-2.34%+41.24%+22.55%-35.57%QNRXQuoin Pharmaceuticals+2.82%+4.04%-0.68%-23.56%-47.54%TNONTenon Medical-2.77%-2.43%-68.32%-75.85%-82.26%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCODXCo-Diagnostics 2.00Hold$67.502,954.30% UpsideHSCSHeartSciences 2.00Hold$8.00227.87% UpsideQNRXQuoin Pharmaceuticals 2.00HoldN/AN/ATNONTenon Medical 2.00HoldN/AN/ACurrent Analyst Ratings BreakdownLatest TNON, QNRX, CODX, and HSCS Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/20/2026QNRXQuoin Pharmaceuticals Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)7/17/2026TNONTenon Medical Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)6/24/2026HSCSHeartSciences Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)6/15/2026QNRXQuoin Pharmaceuticals ThinkEquitySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy6/11/2026CODXCo-Diagnostics Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D-) ➝ Sell (E+)5/26/2026CODXCo-Diagnostics Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E+) ➝ Sell (D-)5/13/2026TNONTenon Medical Alliance Global PartnersSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy(Data available from 7/23/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCODXCo-Diagnostics$620K13.15N/AN/A$9.14 per share0.24HSCSHeartSciencesN/AN/AN/AN/A$0.18 per shareN/AQNRXQuoin PharmaceuticalsN/AN/AN/AN/A$15.64 per shareN/ATNONTenon Medical$3.94M0.59N/AN/A$0.18 per share1.10Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCODXCo-Diagnostics-$46.90M-$15.77N/AN/AN/A-6,760.63%-164.92%-141.15%8/14/2026 (Estimated)HSCSHeartSciences-$8.77M-$4.94N/AN/AN/AN/A-333.50%-140.18%7/23/2026 (Estimated)QNRXQuoin Pharmaceuticals-$15.81M-$29.56N/AN/AN/AN/A-489.85%-221.29%8/6/2026 (Estimated)TNONTenon Medical-$12.56M-$1.29N/AN/AN/A-270.09%-907.60%-110.17%8/12/2026 (Estimated)Latest TNON, QNRX, CODX, and HSCS EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/14/2026Q2 2026CODXCo-Diagnostics-$3.00N/AN/AN/A$0.13 millionN/A8/12/2026Q2 2026TNONTenon Medical-$0.24N/AN/AN/A$1.54 millionN/A8/6/2026Q2 2026QNRXQuoin Pharmaceuticals-$1.61N/AN/AN/AN/AN/A7/23/2026Q4 2026HSCSHeartSciences-$0.66$3.06+$3.72N/A$0.05 million$89.49 million5/14/2026Q1 2026CODXCo-Diagnostics-$3.75-$4.06-$0.31-$4.06$0.13 million$0.15 million5/12/2026Q1 2026TNONTenon Medical-$0.3050-$0.31-$0.0050-$0.31$1.30 million$1.38 million5/7/2026Q1 2026QNRXQuoin Pharmaceuticals-$2.17-$1.77+$0.40-$1.77N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthCODXCo-DiagnosticsN/AN/AN/AN/AN/AHSCSHeartSciencesN/AN/AN/AN/AN/AQNRXQuoin PharmaceuticalsN/AN/AN/AN/AN/ATNONTenon MedicalN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCODXCo-DiagnosticsN/A2.282.09HSCSHeartSciences0.161.191.04QNRXQuoin PharmaceuticalsN/A2.872.87TNONTenon MedicalN/A1.030.92Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCODXCo-Diagnostics14.99%HSCSHeartSciences17.24%QNRXQuoin Pharmaceuticals8.63%TNONTenon Medical22.74%Insider OwnershipCompanyInsider OwnershipCODXCo-Diagnostics5.40%HSCSHeartSciences4.90%QNRXQuoin Pharmaceuticals11.17%TNONTenon Medical17.71%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCODXCo-Diagnostics1003.69 million3.49 millionOptionableHSCSHeartSciences103.18 million3.03 millionNot OptionableQNRXQuoin Pharmaceuticals42.01 million1.78 millionNot OptionableTNONTenon Medical811.85 million9.75 millionNot OptionableTNON, QNRX, CODX, and HSCS HeadlinesRecent News About These CompaniesTenon Medical regains Nasdaq complianceJuly 20 at 6:50 PM | seekingalpha.comTenon Medical Regains Nasdaq Listing Compliance After OfferingJuly 20 at 8:50 AM | tipranks.comTenon Medical, Inc. Announces Regained Compliance with Nasdaq Stockholders' Equity RequirementJuly 20 at 8:00 AM | accessnewswire.comATenon Medical Raises Capital, Regains Nasdaq Equity ComplianceJuly 10, 2026 | tipranks.comTenon Medical Completes $4.2 Million Public OfferingJuly 2, 2026 | tipranks.comTenon Medical(R) Announces FDA 510(k) Clearance for Catamaran(R) SI Joint Fusion SystemJuly 2, 2026 | accessnewswire.comAWallachBeth Capital Announces Closing of Tenon Medical, Inc. $4.2 Million Public OfferingJuly 1, 2026 | prnewswire.comTenon Medical, Inc. Announces Closing of $4.2 Million Public OfferingJuly 1, 2026 | accessnewswire.comATenon Medical prices $4.2M public offeringJune 30, 2026 | msn.comWallachBeth Capital Announces Pricing of Tenon Medical, Inc. $4.2 Million Public OfferingJune 30, 2026 | prnewswire.comTenon Medical, Inc. Announces Pricing of $4.2 Million Public OfferingJune 30, 2026 | accessnewswire.comATenon Medical (TNON) stock jumps nearly 83% after hours: Here's what is going onJune 19, 2026 | msn.comTenon Medical Extends Executive Chairman Consulting AgreementJune 12, 2026 | tipranks.comTenon Medical Updates Bylaws to Ease Shareholder QuorumJune 11, 2026 | tipranks.comTenon Medical Faces Nasdaq Deficiency, Compliance Plan DueMay 22, 2026 | tipranks.comTenon Medical CEO Foster buys $25k in TNON stock and warrantsMay 16, 2026 | investing.comTenon Medical, Inc. (NASDAQ:TNON) Q1 2026 Earnings Call TranscriptMay 13, 2026 | insidermonkey.comTenon Medical Earnings Call Highlights Rapid Growth PivotMay 13, 2026 | tipranks.comTenon(R) Medical Reports First Quarter 2026 Financial ResultsMay 12, 2026 | accessnewswire.comATenon Medical, Inc. Sets Date for First Quarter 2026 EarningsMay 1, 2026 | accessnewswire.comANew MarketBeat Followers Over TimeMedia Sentiment Over TimeTNON, QNRX, CODX, and HSCS Company DescriptionsCo-Diagnostics NASDAQ:CODX$2.21 -0.07 (-3.07%) Closing price 04:00 PM EasternExtended Trading$2.22 +0.02 (+0.68%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction (PCR) testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah.HeartSciences NASDAQ:HSCS$2.44 -0.06 (-2.40%) Closing price 04:00 PM EasternExtended Trading$2.44 0.00 (0.00%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.Quoin Pharmaceuticals NASDAQ:QNRX$4.37 -0.01 (-0.23%) Closing price 04:00 PM EasternExtended Trading$4.39 +0.02 (+0.57%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Quoin Pharmaceuticals, Ltd., a clinical stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases. Its lead product is QRX003, a topical lotion to treat Netherton Syndrome (NS). The company is also developing QRX004 for the treatment of recessive dystrophic epidermolysis bullosa; QRX007 to treat NS; and QRX008 for the treatment of scleroderma. It has a research agreement with Queensland University of Technology; a license agreement with Skinvisible Inc.; consulting agreements with Axella Research LLC; and a Master Service Agreement with Therapeutics Inc. The company was founded in 2018 and is based in Ashburn, Virginia.Tenon Medical NASDAQ:TNON$0.20 +0.00 (+0.10%) Closing price 04:00 PM EasternExtended Trading$0.19 -0.01 (-2.59%) As of 04:26 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Tenon Medical, Inc., a medical device company, engages in the development of surgical implant systems to treat severe lower back pain in the United States and Puerto Rico. The company offers CATAMARAN SI-Joint Fusion System to fuse sacroiliac joints (SI-Joints) to treat SI-Joint dysfunction that often causes severe lower back pain; and features fixation device that passes through the axial and sagittal planes of the ilium and sacrum, as well as transfixes the SI joints. Tenon Medical, Inc. was incorporated in 2012 and is headquartered in Los Gatos, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas AMD’s $5 Billion Anthropic Deal Could Redraw the AI Chip Battle Alphabet Crushed Earnings, But One Number Spooked the Market Premium Retail’s Stress Test Is Separating Winners From Losers GE Vernova Just Sent a Mixed AI Signal to Investors Otis Took Another Guidance Cut—But the Story Isn't Over Philip Morris Trimmed Guidance, But Its Growth Story Looks Unshaken The 2026 Blueprint: 6 Stocks for a Brand New Portfolio Cementing the Sky: Why NVIDIA’s Bet on Nebius Matters Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
